ICD-10-CM Billable Code

C44.319

Basal cell carcinoma of skin of other parts of face

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) is a common type of skin cancer that often develops on areas of the skin exposed to the sun. When located on parts of the face not specified elsewhere, it is classified under ICD-10 code C44.319. BCC originates from basal cells in the skin's lower epidermis, gradually growing over time. Although it rarely spreads to other parts of the body, it can cause local destruction and disfigurement if not treated promptly. Recognizing the signs and understanding the potential causes of this condition can help in early detection and effective management.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Fair skin that burns easily and freckles more readily A history of frequent sunburns, especially during childhood Working outdoors or engaging in outdoor recreational activities Older age, as risk increases with age Immunosuppression due to medications or medical conditions History of skin cancer or precancerous skin lesions

Key Symptoms: A shiny, pearly bump that may appear translucent and have visible blood vessels Pink, red, or flesh-colored lesions that can bleed, scab, or ulcerate Scar-like area that seems swollen, shiny, and waxy Reddish patches with a rough, scaly surface Persistent sores that do not heal or keep reopening A sensation of itchiness, tenderness, or soreness around the lesion Nodules that may develop a central depression or ulcer

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a thorough skin examination by a healthcare professional, focusing on suspicious lesions. To confirm the diagnosis, a skin biopsy may be performed, where a small tissue sample is extracted and examined under a microscope. Imaging tests are rarely needed but can be used if the tumor is suspected to have invaded deeper tissues. Early detection relies on recognizing new or changing skin growths, especially in high-risk individuals.

Treatment Protocols: Treatment options for basal cell carcinoma vary depending on the size, location, and depth of the tumor, as well as the patient's overall health. Common methods include: - Surgical excision: physically removing the tumor with a margin of healthy tissue - Mohs micrographic surgery: a precise technique where the cancer is removed layer by layer, examining each for cancer cells until clear margins are achieved - Curettage and electrodessication: scraping away the lesion and using electric current to destroy remaining cancer cells - Cryotherapy: freezing the tumor with liquid nitrogen - Topical medications: such as imiquimod or 5-fluorouracil creams for superficial BCC - Radiation therapy: in cases where surgery isn't suitable, especially for older patients or difficult-to-reach areas Follow-up with healthcare providers is essential to monitor healing and check for recurrence. Early treatment can effectively manage the condition and prevent complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.319 a billable ICD-10 code?
Yes, C44.319 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.319?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of other parts of face and any associated comorbidities for accurate reporting.

Cite this Clinical Reference